Log In
Print
BCIQ
Print
Print this Print this
 

palovarotene (R667) (formerly CLM-001, RG667)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSelective small molecule retinoic acid receptor gamma (RARG) agonist
Molecular Target Retinoic acid receptor gamma (RARG)
Mechanism of ActionRetinoic acid receptor (RAR) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat fibrodysplasia ossificans progressiva (FOP)
Regulatory Designation

U.S. - Orphan Drug (Treat fibrodysplasia ossificans progressiva (FOP))

Partner

Clementia Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today